Key facts
- This page summarizes Garo H. Armen's Form 4 filing for Protagenic Therapeutics, Inc.\new (PTIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Aug 2026, 20:29.
Garo H. Armen - 05 Aug 2026 Form 4 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)
- Reporting relationship
- EXEC. CHAIR & PRINCIPAL OFF, Director
- Issuer ticker
- PTIX
- Reported as of
- 05 Aug 2026
- Net transaction value
- +$1,294
- SEC form
- 4
- Accepted by SEC
- 06 Aug 2026, 20:29:33 UTC
- Prior SEC filing
- 03 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Garo H. Armen
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Garo H. Armen filed Form 4 for Protagenic Therapeutics, Inc.\new (PTIX) on 06 Aug 2026.
Change
- Previous filing in this sequence was filed on 03 Aug 2026.
- Current net transaction value: +$1,294.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0000935679
Primary reporting owner
ARMEN GARO H
- Relationship
- EXEC. CHAIR & PRINCIPAL OFF, Director
- Address
- C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON,
- Signature
- /s/ Garo H. Armen
- Signature date
- 06 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PTIX
transaction
COMMON STOCK
Purchase
- Transaction value
- $1,294
- Shares
- +5,000
- Change %
- +19%
- Price
- $0.2588
- Shares after
- 31,294
- Date
- 05 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.